arrow
G

Gianluca Avallone

fondazione irccs ca’granda ospedale maggiore policlinico
H指数:22
被引数:1,430

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Real-Life, Multicenter, Retrospective Study on Epidemiological and Clinical Features of Patients With Hidradenitis Suppurativa and Concomitant Down Syndrome

一项关于 Hidradenitis Suppurativa 合并 Down 综合征患者流行病学和临床特征的回顾性、多中心、真实世界研究

2026-09-110
OA
Small lesion, big challenge? Diagnosis of small diameter melanocytic lesions by dermatologists using AI support

小病灶,大挑战?皮肤科医生利用人工智能支持诊断小直径黑色素细胞病变

2026-08-210
OAAI
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area

从度普利单抗转换至lebrikizumab治疗涉及头颈区域的轻中度特应性皮炎的疗效结局

2026-07-220
OAAI
Comprehensive molecular profiling of Hispanic, Black, Asian, and White patients with atopic dermatitis via tape strip RNA sequencing and serum proteomics

通过胶带剥离RNA测序和血清蛋白质组学对患有特应性皮炎的西班牙裔、非裔、亚裔和白人患者的全面分子表征

2026-04-250
PRE
Real-World Effectiveness and Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Italian Study Focusing on Head and Neck Involvement

真实世界中利rikizumab在成人和青少年中重度特应性皮炎患者中的有效性与安全性:一项为期52周的意大利回顾性研究,重点关注头颈部受累情况

2026-03-280
OAAI
GWTC-4.0: An Introduction to Version 4.0 of the Gravitational-Wave Transient Catalog

GWTC-4.0:引力波暂现源目录4.0版本的介绍

2025-12-090
OA
International Multi-Center Case Series of Gestational Dupilumab Exposure in the Treatment of Atopic Dermatitis: Maternal Complications and Fetal Outcomes

国际多中心病例系列研究:妊娠期Dupilumab暴露于特应性皮炎治疗中的母体并发症和胎儿结局

2025-10-290
PRE
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study

有效性、安全性及与健康相关的生活质量:接受Lebrikizumab治疗的轻中度特应性皮炎的16周全国性回顾性队列研究

2025-10-100
OA
Therapeutic outcomes across Janus kinase inhibitors in prurigo nodularis

结节性痒疹中Janus kinase抑制剂的疗效比较

2025-09-010
PRE